Webinars

Overview of Annex 1 - Modifications and Impacts

AdobeStock_93964460-2_0.jpg

DATE

15 May 2020
(Duration : 90 mins)

 

SPEAKER

Gilberto DALMASO,
Pharma and Medical Devices Consulting Owner at GDM Pharma Consulting

Félix MONTERO,
bioMérieux Industry Global Scientific Director

 

WEBINAR OVERVIEW

Overview of Annex 1 modifications and impacts.

 

 

img6FELIX-MONTERO-JULIAN-PHD-BIOMERIEUX
Written by
Felix
MONTERO-JULIAN PhD

Scientific Director Healthcare Business
Healthcare Business Industry Unit
bioMérieux SA, France

Picture Gilberto DALMASO2.jpg
Written by
Gilberto
DALMASO

Pharma and Medical Devices Consulting Owner
GDM Pharma Consulting

Do you need to talk to our microbiology experts to find the right solution for you, to know if the product is available in your country ?